Ketamine, a dissociative anesthetic, has carved itself a spot in the world of mental health care over the past two decades.
Bryan Johnson injected himself with ketamine, a hallucinogen favored by Elon Musk, for 15 days. He used a helmet from his ...
The FDA has approved Janssen’s antidepressant ... who have cycled through multiple treatments without relief. Spravato (esketamine) has been touted as a potential blockbuster for Janssen ...
IntroductionMajor depressive disorder (MDD) is a leading cause of disability worldwide, with a significant proportion of patients (10-20%) progressing ...
Escalating concerns over impending tariffs and President Trump's foreign policies have fueled uncertainty and instability in ...
6d
News Medical on MSNExploring ketamine's potential in the fight against treatment-resistant depressionMajor depressive disorder (MDD) is a leading cause of disability worldwide, with a significant proportion of patients (10-20%) progressing to treatment-resistant depression (TRD).
The FDA approved Ospomyv and Xbryk ... or myelodysplastic syndrome (MDS). Esketamine (Spravato; Johnson & Johnson) is now the first and only monotherapy for adults with major depressive disorder ...
6d
Pharmaceutical Technology on MSNSupernus’s stock sinks after depression drug fails trialThe company announced on 18 February that the trial did not meet its primary endpoint measured by a depression rating scale, ...
Trump’s “first buddy” Elon Musk made a lively, chaotic and unpredictable appearance at the Conservative Political Action ...
China: A recent randomized clinical trial has highlighted the potential benefits of intraoperative esketamine in reducing postpartum depression (PPD) among women undergoing cesarean delivery. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results